Breakfast with Master 1 
Beyond the Clinical Trial Data : Impact of Real-World Experience of ZEPOSIA®
|
Room B |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Hyun Soo Kim (Chonnam National University, Korea) |
| Speaker(s) |
07:30-08:00 |
Refining Evidence-Based Strategies in UC Practice: Positioning Ozanimod Based on Real-World Experience in Korea
Dong Hyun Kim (Chonnam National University, Korea) |
Breakfast with Master 2 
Sequential Treatment in Ulcerative Colitis
|
Room C |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Sang Wook Kim (Jeonbuk National University, Korea) |
| Speaker(s) |
07:30-08:00 |
The Current Role of Filgotinib in Ulcerative Colitis
Fumihito Hirai (Fukuoka University, Japan) |
Breakfast with Master 3 
Start Strong in Ulcerative Colitis with Upadacitinib
|
Room D |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Geom-Seog Seo (Wonkwang University, Korea) |
| Speaker(s) |
07:30-07:45 |
When Time Matters in Ulcerative Colitis: Upadacitinib for Urgent Disease Control
Dong Hoon Baek (Pusan National University, Korea) |
| 07:45-08:00 |
Connecting the Dots: Evidence to Insight with Upadacitinib
Sang-Bum Kang (The Catholic University of Korea, Korea) |
Breakfast with Master 4 
Transforming Bowel Preparation Strategies in IBD: A Change in Perspective Toward Mini Oral Sulfate Tablets
|
Room E |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Jae Myung Cha (Kyung Hee University, Korea) |
| Speaker(s) |
07:30-08:00 |
Transforming Bowel Preparation Strategies in IBD: A Change in Perspective Toward Mini Oral Sulfate Tablets
Jaeseung Soh (Hallym University, Korea) |
Breakfast with Master 5 
New and Now: Introducing Etrasimod in Ulcerative Colitis
|
Room F |
| Date & Time
|
June 26 (Fri), 07:30-08:00 |
| Chair(s) |
Jae Hee Cheon (Yonsei University, Korea) |
| Speaker(s) |
07:30-08:00 |
Etrasimod in Ulcerative Colitis: Clinical Evidence and Its Role in Therapy
David T. Rubin (University of Chicago, USA) |
Luncheon Symposium 2 
Beyond Similarity: Clinical and Real-World Insights into Ustekinumab Biosimilars
|
Room B |
| Date & Time
|
June 26 (Fri), 12:20-13:00 |
| Chair(s) |
Katsuyoshi Matsuoka (Toho University, Japan)
Jonghun Lee (Dong-A University, Korea) |
| Speaker(s) |
12:20-12:40 |
What is Same and Different? : Clinical Value of Ustekinumab Biosimilar
Eun Soo Kim (Kyungpook National University, Korea) |
| 12:40-13:00 |
From Evidence to Experience: Real-World Application of Ustekinumab Biosimilar in Inflammatory Bowel Disease
Sang Hyoung Park (University of Ulsan, Korea) |
Luncheon Symposium 3 
Evolving IBD Care in the Era of IL-23 Inhibitor
|
Room C |
| Date & Time
|
June 26 (Fri), 12:20-13:00 |
| Chair(s) |
Masayuki Saruta (Jikei University, Japan)
Young-Ho Kim (Sungkyunkwan University, Korea) |
| Speaker(s) |
12:20-12:35 |
Unmet Needs in Korean IBD Care: Evolving Expectations for New Therapeutic Options
Seong-Joon Koh (Seoul National University, Korea) |
| 12:35-13:00 |
Advancing IBD Care with Guselkumab: Insights from Clinical and Real World Evidence
David T. Rubin (University of Chicago, USA) |
|
Luncheon Symposium 4
Fast-Acting, Long-Lasting Control: Upadacitinib in IBD
|
Room B |
| Date & Time
|
June 26 (Fri), 13:00-13:40 |
| Chair(s) |
Zhihua Ran (Shanghai University, China)
Sung-Ae Jung (Ewha Womans University, Korea) |
| Speaker(s) |
13:00-13:20 |
Optimizing Treatment Strategies in Ulcerative Colitis with Upadacitinib
Byong Duk Ye (University of Ulsan, Korea) |
| 13:20-13:40 |
Shaping a New Paradigm in Crohn’s Disease Management: The Role of Upadacitinib
Edward V. Loftus Jr. (Mayo Clinic College of Medicine and Science, USA) |
Luncheon Symposium 5 
A New Era in IBD Treatment: Optimizing Infliximab Therapy
|
Room C |
| Date & Time
|
June 26 (Fri), 13:00-13:40 |
| Chair(s) |
Zhanju Liu (Tongji University, China)
Yoon Tae Jeen (Korea University, Korea) |
| Speaker(s) |
13:00-13:20 |
Real-World Experience with Subcutaneous Infliximab: Updated Global Evidence
Silvio Danese (University Vita-Salute San Raffaele, Italy) |
| 13:20-13:40 |
Personalizing IBD Treatment: The Role of Therapeutic Drug Monitoring in Infliximab Therapy
Sung Noh Hong (Sungkyunkwan University, Korea) |
|
Meet the Expert 1
Advancing IBD Care with Subcutaneous Infliximab
|
Exhibition |
| Date & Time
|
June 26 (Fri), 15:50-16:20 |
| Speaker(s) |
15:50-16:20 |
Redefining IBD Treatment Strategies: The Role of Subcutaneous Infliximab
Rupert Leong (University of Sydney, Australia) |
|
Meet the Expert 2
Emerging Treatment in Crohn’s Disease with Fistula
|
Exhibition |
| Date & Time
|
June 26 (Fri), 15:50-16:20 |
| Speaker(s) |
15:50-16:20 |
Clinical Efficacy and Real World Experience with Guselkumab in CD with Fistula
Vipul Jairath (Western University, Canada) |
